Archive for the ‘vaccines’ Category

UMD Researcher Awarded New Funds From the Steven & Alexandra Cohen Foundation to Head Off Tick-borne Infection Before It Begins

https://agnr.umd.edu/news/umd-researcher-awarded-new-funds-steven-alexandra-cohen-foundation-head-tick-borne-infection

UMD Researcher Awarded New Funds from the Steven & Alexandra Cohen Foundation to Head Off Tick-borne Infection Before it Begins

May 13, 2021 SAMANTHA WATTERS

The University of Maryland (UMD) received new funding from the Steven & Alexandra Cohen Foundation to develop novel therapeutic strategies that have the potential to stop infection from Lyme disease pathogens before it begins. Unlike traditional antibiotic treatments for Lyme disease that attack the pathogen directly and put it on the defensive, Utpal Pal and his team in the UMD Department of Veterinary Medicine are working in close collaboration with the National Institutes of Health’s National Center for Advancing Translational Sciences (NIH-NCATS) to explore antimicrobials that would interfere with the pathogen on a biomolecular level to inhibit it from causing an infection in the first place. This work has the potential to greatly reduce the burden of Lyme disease, and particularly Post-Treatment Lyme Disease Syndrome (PTLDS) that does not respond to traditional antibiotic treatments. This grant is one of several new and ongoing projects led by Pal that seek to translate basic research into treatments and vaccines to fight and prevent tick-borne diseases. 

“This technology we are exploring with the support of the [Steven & Alexandra Cohen] Foundation is very exciting,” says Pal. “Instead of how antibiotics attack the basic housekeeping and maintenance functions of Borrelia [Borrelia burgdorferi, the pathogen that causes Lyme disease], these new antimicrobials would attack essential protein-to-protein interactions. We identified two proteins in our previous research whose interaction is important for infection. In collaboration with NIH-NCATS, we then came up with a select set of compounds that inhibit the protein interaction. The grant will allow us to conduct preclinical testing to see whether treatment with that compound can actually prevent infection.”

As Pal describes it, the infection process of Borrelia and the emergence of more cases of PTLDS could possibly require a solution beyond current antibiotic treatments. Lyme disease has now been reported in more than 80 countries, with an estimated 476,000 annual recent cases in the U.S. alone. While early treatment with antibiotics can be quite effective, the later the illness is discovered, the more difficult it becomes to treat. Borrelia is a notoriously tricky bacteria that has evolved to persist in mammals on a long-term basis, and some of Pal’s previous work has shown how the pathogen has the ability to  outsmart the immune system and persist in the body for long periods of time. While the causes are currently unknown, many think this process may have something to do with PTLDS, a chronic and variable resurgence of Lyme disease symptoms months or years after treatment that comes with a series of cognitive, neurological, and inflammation issues. In this case, antibiotics do nothing, and there is no known cause or current cure. 

“Lyme disease-causing Borrelia can hide and survive in an antibiotic treated animal, but we don’t know if that is the case in humans,” says Pal. “People have a lot of theories about PTLDS, but right now, we don’t have a complete answer or a cure. The best way to reduce the occurrence of PTLDS and Lyme disease in general is to prevent the bacterial transmission, such as via vaccines, or to use new antimicrobials that stop the infection more completely.”

Tick mouth parts

 

Scanning electron micrograph of tick mouth parts, Pal lab

This grant is one example of recent and ongoing sources of research funding to reduce the burden of tick-borne disease as a whole through the development of novel therapeutic and vaccine strategies. Utpal Pal leads theTick Immunity project, uncovering the secrets of tick immune responses that could help to develop treatments and vaccines, as well as a recent grant to develop anovel Lyme disease vaccine. But ticks transmit many human and animal illnesses each year in addition to causing Lyme disease. Despite substantial efforts, vaccines against most tick-borne diseases are still unavailable. Since ticks transmit most pathogens into their host’s skin while they are feeding, a new invention disclosure that was nominated for UMD Life Sciences Invention of the Year identifies a set of novel tick antigens or vaccine targets which could potentially be developed as anti-tick bite vaccines. The successful development of vaccines against tick bites would thwart the transmission of pathogens, thereby reducing the incidence of tick-borne infections as a whole. 

“This is an exciting innovation disclosure that has the potential to translate some basic scientific discoveries into public health improvement,” says Pal. “These studies address unique aspects of tick biology and pathogen transmission, and our laboratory continues to explore ways that diseases like Lyme disease can be avoided altogether.”

About the Steven & Alexandra Cohen Foundation

The Steven & Alexandra Cohen Foundation is committed to inspiring philanthropy and community service by creating awareness, offering guidance, and leading by example to show the world what giving can do. The Foundation’s grants support nonprofit organizations based in the United States that either help people in need or solve complex problems. The Foundation also spearheads grassroots campaigns to encourage others to give. For more information, visitwww.steveandalex.org.

_______________________

**Comment**

A few points:

  • Lyme advocate emphatically states there should be no Lyme vaccine until persistent infection is acknowledged and fully addressed.  I couldn’t agree more.
  • This resource gives updates & updates, including a link to 700 scientific articles on borrelia persistence as well as the fact Lyme is transmitted congenitally, a detail our corrupt public health ‘authorities’ continue to state is rare, even though nobody’s counting?
  • Working with the NIH is a big mistake.  Insanity is doing the same thing over and over and expecting different results.  Lyme science is owned by The Cabal and hasn’t budged in over 40 years. Entrance criteria into studies requires a positive 2-tiered CDC test and the EM rash. There is a large subset of patients, usually the sickest, who will never be studied due to this.
  • While Pal admits the organism can persist in the human body for a long time, he continues to abide by the faulty PTLDS moniker that essentially blames remaining symptoms on anything but persistent infection. They continue to say they don’t know what causes PTLDS despite science and decades of clinical experience showing long term antimicrobials help patients. Researchers who straddle the fence on this issue are playing a game and are not to be trusted.  The reason for it is simple: they want government money and those accepting this money must tout an accepted narrative.
  • The “novel vaccine” they are developing is using the rabies virus as a delivery platform to send in some vaccine candidates for Borrelia.” The researchers state that by using the virus platform, they won’t need adjuvants because the virus itself acts as an adjuvant which often produces a strong immune response.
  • Herein lies the problem.  Lyme/MSIDS patients already have dysfunctional immune systems.  Some are so sensitive they have to quit eating dairy, gluten, sugar, avoid EMF, fragrances, and much more.  They are extremely sensitive to any changes with supplements and medications. Do you really thing it’s wise to directly pump something into the body that produces a strong immune response?  
  • Researchers are often very myopic in their focus.  They have to be.  Their line of work requires it.  But this myopic thinking does not help extremely ill patients who all look differently, respond differently, and have complex cases that take time to unravel and treat.  Even the best doctors struggle with these patients.
  • Please note again the thrust on vaccines.  They briefly mention “therapeutic” strategies almost as a requirement but then go on to the topic of vaccines.  If we need anything – it’s effective treatment!
  • Lastly, please note that the same University (Massachusetts) is also developing another “new vaccine” to supposedly prevent Lyme in humans. It is led by none other than Dr. Mark Klempner, the man behind a  flawed study that is still being used to keep chronically sick Lyme/MSIDS patients from extended treatment.  ILADS points out that the Klempner trial relied on average treatment effects, employed small samples (ranging from 37-129), and excluded over 89% of patients who sought to enroll.
Dr. Klempner has been in this game a long, long time.  

He was also the director the BU Biodefense Laboratory.

Excerpt:  

In February 2003, Boston University (BU) submitted a proposal to the NIH to construct a facility with the highest-risk level bioweapons research laboratory (called a BSL-4 laboratory) that would be sited within the BU Medical Center. The medical center is located in a dense, urban neighborhood with a majority of low-income and minority residents nearby. The process of proposal development, site selection and subsequent approval for funding took place in secret,without informing and consulting the local community. The site selected for the laboratory was pre-determined prior to BU undertaking a National Environmental Policy Act (NEPA) mandated environmental impact review and without involving the surrounding residential and working community – all in violation of federal policy. Nonetheless, NIH approved BU Medical Center’s proposal for $128 million.

This would of course yield billions as you would be forced to get a yearly booster shot.

This ‘pre-exposure prophylaxis’ (PrEP) delivers anti-Lyme antibodies, and are “unlike vaccines” which trigger the immune system to produce antibodies. PrEP supplies the antibodies directly and kills the bacteria before a person becomes infected.  

Before you believe everything they say, you might want to read this.

As you can clearly see, this injection contains OspA, the same outer surface protein found to cause severe adverse reactions in the first Lyme vaccine called Lymerix.  (Please read about the bitter history of how our public ‘authorities’ eliminated from the Western blot two Bb proteins, outer surface protein A (OspA), from which LYMErix was made, and outer surface protein B (OspB), the intended component of next-generation vaccines. This has kept the sickest from being diagnosed.)

 

Immunity to COVID May Last Years

https://www.nytimes.com/2021/05/26/health/coronavirus-immunity-vaccines.html

Immunity to the Coronavirus May Persist for Years, Scientists Find

Important immune cells survive in the bone marrow of people who were infected with the virus or were inoculated against it, new research suggests.
The studies may soothe fears that immunity to the virus is transient, as is the case with coronaviruses that cause common colds.
Credit…Christopher Capozziello for The New York Times

Immunity to the coronavirus lasts at least a year, possibly a lifetime, improving over time especially after vaccination, according to two new studies. The findings may help put to rest lingering fears that protection against the virus will be short-lived.

Together, the studies suggest that most people who have recovered from Covid-19 and who were later immunized will not need boosters. Vaccinated people who were never infected most likely will need the shots, however, as will a minority who were infected but did not produce a robust immune response.

Both reports looked at people who had been exposed to the coronavirus about a year earlier. Cells that retain a memory of the virus persist in the bone marrow and may churn out antibodies whenever needed, according to one of the studies, published on Monday in the journal Nature.

The other study, posted online at BioRxiv, a site for biology research, found that these so-called memory B cells continue to mature and strengthen for at least 12 months after the initial infection.

“The papers are consistent with the growing body of literature that suggests that immunity elicited by infection and vaccination for SARS-CoV-2 appears to be long-lived,” said Scott Hensley, an immunologist at the University of Pennsylvania who was not involved in the research.  (See link for article)

_____________________

**Comment**

A few points:

  • According to Dr. Peter McCullough as well as history, you can’t beat “natural” immunity. (Getting the virus naturally).  He also states you can not improve natural immunity with “vaccines”. Recently a Johns Hopkins professors states to “ignore the CDC” due to their refusal to recognize natural immunity from previous infection. The WHO also recently changed the definition of herd immunity to now only come from vaccines, essentially rewriting hundreds of years of scientific understanding.
  • There is ample evidence that those who have already had COVID should NOT get “vaccinated.” Dr. Hooman Noorchashm has repeatedly warned the FDA that “clear and present danger” exists for those who have had COVID-19 and subsequently get vaccinated due to viral antigens that remain in the body after a person is naturally infected; the immune response reactivated by the COVID-19 vaccine may trigger inflammation in tissues where the viral antigens exist. An international survey of 2,002 people found that people who had previously had COVID-19 experienced “significantly increased incidence and severity” of side effects after the COVID-19 vaccine
  • It’s important to remember that COVID injections are part of a grand experiment where final data is unknown. These are experimental, fast-tracked injections that have not undergone rigorous testing.
  • There are many reported deaths and severe adverse reactions after obtaining the injections.
  • There are many reported “break-through” cases of COVID after being fully “vaccinated,” demonstrating the injections do not stop you from becoming ill, or from dying. Public health ‘authorities’ are downplaying this, yet have counted at least 10,000 such cases. The true number is likely to be much higher. The CDC has even changed testing criteria for the “vaccinated” and is now only counting hospitalized cases, further lowering reported numbers.
  • They make a distinction that those who have not had COVID may need future booster shots.  The question begging to be asked is why get “vaccinated” at all when “natural” immunity is more complete?  Further, the Washington University study clearly demonstrates what has taken place in reality: the majority who get COVID have mild cases.
  • Also, falling antibody levels after infection is completely normal and does not signal waning immunity, because B cells remain in bone marrow, ready to mobilize when needed . A landmark 2007 study showed antibodies in theory, “could survive decades – perhaps well beyond the average life span – hinting at the long-term presence of memory B Cells.”
  • The same study found out of 19 patients, 15 had detectable memory B cells, but because FOUR didn’t they are suggesting “vaccination,” for all after infection. The immune system is complex. To suggest “vaccinating” the entire world based on the results of FOUR people is unfounded and reeks of bias.
  • The study found the number of memory B cells remained stable over time.
  • They make an example out of a Kentucky Senator (who happens to be a MD) who stated he would not get the COVID “vaccine” because he had already been infected and was immune. The authors state there is no such guarantee that this immunity will be powerful enough.  Imagine, again, someone stating this for Chicken Pox.  It isn’t done.  If COVID-19, which has never been completely purified and isolated, is more like the flu, then we need to have a serious discussion about the fact the flu vaccine, depending upon the year, has an effectiveness from 10%-43%.  The flu vaccine, similarly to the COVID shots, does not prevent the spread of the flu, does not reduce demands upon hospitals, does not reduce death, and increases risk of contracting non-flu respiratory illness by 65%. Source  The flu vaccine increases Coronavirus infection risk by 36%. Source
  • It’s obvious that the goal of this article is to push “vaccination” upon those who have already have COVID.   Even vaccine experts are giving stern warnings.  It’s interesting to note that only half of NIH employees have gotten the jab.

Important quote:

The experts all agreed that immunity is likely to play out very differently in people who have never had Covid-19. Fighting a live virus is different from responding to a single viral protein introduced by a vaccine.

US Senate Hearing: Little Over Half of NIH, FDA Employees Got COVID JAB

https://www.lifesitenews.com/news/us-senate-hearing-reveals-only-a-little-over-half-of-nih-fda-employees-have-taken-coronavirus-vaccine

US Senate hearing reveals only a little over half of NIH, FDA employees have taken coronavirus vaccine

Testifying before the U.S. Senate, Dr. Anthony Fauci said ‘a little bit more than half, probably around 60 percent’ of employees have taken one of the experimental COVID-19 vaccines. The CDC’s Dr. Rochelle Walesnsky said she doesn’t know how many CDC employees are vaccinated.
Mon May 24, 2021 
Featured Image

WASHINGTON, D.C., May 24, 2021 (LifeSiteNews) – Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), said during a U.S. Senate hearing that he estimates just under half of employees at the NIH have not taken a COVID-19 vaccine.  (See link for article)

____________________________

**Comment**

Director of the CDC, Dr. Walesnsky doesn’t know how many CDC workers have taken the jab because neither the injections nor reporting of injections is mandated for employees.

The article points out that Reuters immediately swung into “fact-check” mode so the public wouldn’t develop any sort of “vaccine” hesitancy.

“This fact-check is technically correct only,” Media Research Center Vice President Dan Gainor told LifeSiteNews. “Yes, the quote [about ‘refusing’] appears to be wrong, but that’s not why Reuters went after it. This is a narrative check.”

“If ordinary Americans realize even a large number of people at government health agencies aren’t getting the vaccine, then they might not as well,” he explained. “That’s become the main goal of so-called fact-checks — to push a media-approved narrative. These fact-checks are then used to lower the number of people who see content the press doesn’t approve of and, in some cases, ban those outlets entirely. For daring to disagree.”

Make sure to be aware of the backstory surrounding all of this.

Be aware of the many deaths and adverse reactions after these injections.

For more:

If You’ve Had COVID, Please Don’t Get Vaccinated

https://articles.mercola.com/sites/articles/archive/2021/05/24/delay-vaccination-for-people-with-covid-19-infections.aspx?  Interview with Dr. Noorchashm in Link

If You’ve Had COVID, Please Don’t Get Vaccinated

Analysis by Dr. Joseph MercolaFact Checked  May 24, 2021
STORY AT-A-GLANCE
  • An international survey of 2,002 people found that people who had previously had COVID-19 experienced “significantly increased incidence and severity” of side effects after the COVID-19 vaccine
  • Dr. Hooman Noorchashm has repeatedly warned the FDA that “clear and present danger” exists for those who have had COVID-19 and subsequently get vaccinated
  • At issue are viral antigens that remain in the body after a person is naturally infected; the immune response reactivated by the COVID-19 vaccine may trigger inflammation in tissues where the viral antigens exist
  • The inner lining of blood vessels, the lungs and the brain may be particularly at risk of such inflammation and damage, which could lead to major thromboembolic complications
  • Noorchashm believes that people should be screened for SARS-CoV-2 viral proteins prior to COVID-19 vaccination, while vaccination should be delayed for people with symptomatic or asymptomatic COVID-19 infections, as well as those who have recently recovered from the virus

In their race to vaccinate the entire U.S. adult population, health officials are urging everyone to get a COVID shot, regardless of whether or not they’ve already been infected with SARS-CoV-2, the virus that causes COVID-19, and spending billions of dollars in taxpayer funded propaganda to convince people to get the vaccine.

This is an important distinction, however, with at least one scientist warning the U.S. Food and Drug Administration that “clear and present danger” exists for those who have had COVID-19 and subsequently get vaccinated.

That scientist — Dr. Hooman Noorchashm, a cardiac surgeon and patient advocate — warned the FDA that prescreening for SARS-CoV-2 viral proteins may reduce the risk of injuries and deaths following vaccination, as the vaccine may trigger an adverse immune response in those who have already been infected with the virus.1

Unfortunately, health agencies continue to assert that everyone should get vaccinated, even if they’ve already acquired natural immunity via previous infection.

CDC: Get Vaccinated Even if You’ve Had COVID

The U.S. Centers for Disease Control and Prevention admits that it’s rare to get sick again if you’ve already had COVID-19. Despite this, they say those who have recovered from COVID-19 should still get vaccinated:2

“You should be vaccinated regardless of whether you already had COVID-19. That’s because experts do not yet know how long you are protected from getting sick again after recovering from COVID-19. Even if you have already recovered from COVID-19, it is possible — although rare — that you could be infected with the virus that causes COVID-19 again.”

Your immune system is designed to work in response to exposure to an infectious agent. Upon recovery, you’re typically immune to that infectious agent. This is why, for instance, proof of prior diagnosis with chickenpox, measles and mumps is allowed instead of vaccination to enter most U.S. public schools3 — once you’ve had the disease and recovered, you’re immune.

If you’ve had COVID-19, you have some level of immunity against the virus. It’s unknown how long it lasts, just as it’s unknown how long protection from the vaccine lasts. According to the Public Health Agency of Sweden:4

“If you have had COVID-19, you have some protection against reinfection. This means that you are less likely to become infected and seriously ill, and less likely to infect others if you are exposed to the virus again.

Over time, the protection that you get after an infection wanes and there is an increased risk of getting infected again. At present, we estimate that the protection after having had COVID-19 lasts at least six months from the time of infection.”

People With Prior COVID Have More Vaccination Side Effects

An international survey of 2,002 people who had received a first dose of COVID-19 vaccine found that people who had previously had COVID-19 experienced “significantly increased incidence and severity” of side effects after the COVID-19 vaccine.5 Those who had previously had COVID-19 had a greater risk of experiencing any side effect, along with the following, specifically:

Fever

Breathlessness

Flu-like illness

Fatigue

Local reactions

Severe side effects leading to hospital care

The mRNA COVID-19 vaccines were linked to a higher incidence of side effects compared to the viral vector-based COVID-19 vaccines, but the mRNA side effects tended to be milder, local reactions. Systemic reactions, such as anaphylaxis, flu-like illness and breathlessness, were more likely to occur with the viral vector COVID-19 vaccines.

According to the researchers, the findings should prompt health officials to reevaluate their vaccination recommendations for people who’ve had COVID-19:6

“People with prior COVID-19 exposure were largely excluded from the vaccine trials and, as a result, the safety and reactogenicity of the vaccines in this population have not been previously fully evaluated. For the first time, this study demonstrates a significant association between prior COVID19 infection and a significantly higher incidence and severity of self-reported side effects after vaccination for COVID-19.

Consistently, compared to the first dose of the vaccine, we found an increased incidence and severity of self-reported side effects after the second dose, when recipients had been previously exposed to viral antigen.

In view of the rapidly accumulating data demonstrating that COVID-19 survivors generally have adequate natural immunity for at least 6 months, it may be appropriate to re-evaluate the recommendation for immediate vaccination of this group.”

Surgeon Warns of Immunological Dangers, Blood Clots

Noorchashm has written multiple letters to the FDA, warning them that people should be screened for SARS-CoV-2 viral proteins prior to COVID-19 vaccination. Without such screening, he wrote in one letter to the FDA, “this indiscriminate vaccination is a clear and present danger to a subset of the already infected.”7

He describes the case of 32-year-old Benjamin Goodman of New York, who died within one day of receiving the Johnson & Johnson COVID-19 vaccine.

“There will be many more in the coming months as we carelessly and indiscriminately vaccinate the already infected, millions a day … It is a near certainty,” he continued.8 At issue are viral antigens that remain in the body after a person is naturally infected.

The immune response reactivated by the COVID-19 vaccine may trigger inflammation in tissues where the viral antigens are present. The inner lining of blood vessels, the lungs and the brain may be particularly at risk of such inflammation and damage.9 According to Noorchashm:10

“Most pertinently, when viral antigens are present in the vascular endothelium, and especially in elderly and frail with cardiovascular disease, the antigen specific immune response incited by the vaccine is almost certain to do damage to the vascular endothelium.

Such vaccine directed endothelial inflammation is certain to cause blood clot formation with the potential for major thromboembolic complications, at least in a subset of such patients. If a majority of younger more robust patients might tolerate such vascular injury from a vaccine immune response, many elderly and frail patients with cardiovascular disease will not.”

What’s more, Noorchashm quotes one of his previous medical school professors, who said, “the eyes do not see what the mind does not know.” In the case of a vaccine-induced antigen specific immune response, which may trigger thromboembolic complications 10 to 20 days after vaccination, including in those who may already be elderly and frail, the reaction isn’t likely to be registered as a vaccine-related adverse event.

Immediately Delay Vaccination for These Key Groups

In his repeated letters to the FDA, Noorchashm suggests that the FDA “immediately and at the very minimum” delay COVID-19 vaccination for people with symptomatic or asymptomatic COVID-19 infections, as well as those who have recently recovered from the virus.

Because so many cases are asymptomatic, he recommends clinicians “actively screen as many patients with high cardiovascular risk as is reasonably possible, in order to detect the presence of SARS-CoV-2, prior to vaccinating them.”11 As it stands, Noorchashm points out that by ignoring what he believes to be an imminent risk for a sizable minority of people, the FDA’s credibility, and that of the mass vaccination campaign in general, is at grave risk:12

“Can you imagine if the public, without having received any real warning from FDA, becomes aware of an increasing number of such vascular/thromboembolic complications? What do you suppose will happen to the level of ‘vaccine hesitancy’ then?

And, what kind of accountability do you think the public will demand from our experts and federal regulators — especially if they knew, or should have known, that this immunological danger might exist?

The aim of benefiting the majority of our public and saving the nation from this pandemic by quick and aggressive vaccination is an ethically sound one — but where we know of real or likely risks of harm and mortality, we ought to mitigate the risks to those in potential harm’s way.

So doing is the only reasonable, ethical, and likely legal option you can pursue as public health regulators — for in America, we no longer sacrifice the lives of minority subsets of people for the benefit of the majority.”

At least 62 cases of myocarditis, or heart inflammation, in people who received the Pfizer COVID-19 vaccine are being investigated by the Israel Health Ministry. Most of the cases occurred in men under the age of 30 who were in good health, and two deaths have been reported as a result.13,14

No Proof of Efficacy in People Who’ve Had COVID-19

In a high-profile report issued by the CDC’s Advisory Committee on Immunization Practices, 15 scientists stated that the Pfizer-BioNTech COVID-19 vaccine had “consistent high efficacy” of 92% or more among people with evidence of previous SARS-CoV-2 infection.15

But according to Rep. Thomas Massie, R-Ky, “That sentence is wrong.”

There is no efficacy demonstrated in the Pfizer trial among participants with evidence of previous SARS-CoV-2 infections and actually there’s no proof in the Moderna trial either.”16 In France, the health body la Haute Autorité de Santé (HAS) does not recommend routinely vaccinating those who have already recovered from COVID-19, stating:17

“At this stage, there is no need to systematically vaccinate people who have already developed a symptomatic form of Covid-19 unless they wish to do so following a decision shared with the doctor and within a minimum period of time. 3 months from the onset of symptoms.”

When Massie realized that vaccination didn’t change the risk of infection among people who’ve had COVID-19, he was alarmed and contacted the CDC directly, recording his calls.

“It [the CDC report] says the exact opposite of what the data says. They’re giving people the impression that this vaccine will save your life, or save you from suffering, even if you’ve already had the virus and recovered, which has not been demonstrated in either the Pfizer or the Moderna trial,” Massey says in a “Full Measure” report.18

CDC Allows Misinformation to Continue

Massie spoke with multiple officials on numerous occasions, who acknowledged the misinformation and implied that it would be fixed.19,20 It wasn’t until Massie’s final call with the CDC, to deputy director Dr. Anne Schuchat, that it was acknowledged that a correction was necessary.

“As you note correctly, there is not sufficient analysis to show that in the subset of only the people with prior infection, there’s efficacy. So, you’re correct that that sentence is wrong and that we need to make a correction of it. I apologize for the delay,” Schuchat said. January 29, 2021, the CDC did finally issue a correction, which reads:21

“Consistent high efficacy (≥92%) was observed across age, sex, race, and ethnicity categories and among persons with underlying medical conditions. Efficacy was similarly high in a secondary analysis including participants both with or without evidence of previous SARS-CoV-2 infection.”

Instead of fixing the error, Massie believes the wording just phrases the mistake in a different way and still misleadingly suggests vaccination is effective for those previously infected.22 Meanwhile, increasing numbers of breakthrough COVID-19 cases among the fully vaccinated are being reported, which the CDC has been reporting.

As of April 26, 2021, there have been 9,245 reported cases of COVID-19 in fully vaccinated individuals, including 132 deaths.23 Note this is not total deaths from the vaccine, which is rapidly approaching 4,000.

However, May 14, 2021, the CDC announced it will no longer report breakthrough cases unless they involve hospitalization or death,24 which will obscure the actual number of breakthrough cases occurring, artificially driving down rates and making the vaccines appear to be more effective.

The CDC also changed recommendations on PCR tests for the fully vaccinated, which will further drive down the appearance of breakthrough cases by making them less likely to “test positive.”

PCR tests recommended by the WHO used to be set to 45 cycle thresholds (CTs),25 yet the scientific consensus has long been that anything over 35 CTs renders the test useless,26as the accuracy will be extremely low, with false positives artificially driving up case numbers.

In April 2021, the CDC recommended the CT be lowered to 28, but only for people who are fully vaccinated.27 Under this guidance, someone with a CT of 30 would not be considered to have COVID-19 if they were fully vaccinated, but if they were not, then their test would be “positive.” 

This is beyond obvious that they are rigging the system to create data that fit their fake narrative, which is pushing the entire population to get a vaccine they don’t need, will harm or kill them and which will generate tens of billions of dollars in annual recurring revenue for the drug companies.

In return, the drug companies have no legal risk for any complications, adverse effects or deaths and are given billions of dollars in free advertising from the U.S. taxpayers to get this dangerous gene therapy.

The Big Lie — Natural Infection Isn’t Adequate

Why is it that the media continue to promote the fake narrative that natural immunity — the type acquired by getting infected by and recovering from a virus — isn’t as powerful or long-lasting as vaccine-acquired immunity?28,29 Do you think it might be to support vaccine sales?

Did they forget that COVID-19 vaccines aren’t intended to be a long-term solution, and have NEVER been shown to provide immunity benefits? The original warp speed test only showed reduced symptoms.

Pfizer’s CEO Albert Bourla exacerbated this charade by stating that not only will people need a third booster dose of COVID-19 vaccine within 12 months of being fully vaccinated, but annual vaccination will probably be necessary.30

Robust natural immunity has been demonstrated, however, for at least eight months after infection in more than 95% of people who have recovered from COVID-19.31,32 A Nature study also demonstrated robust natural immunity in people who recovered from SARS and SARS-CoV-2.33

There continue to be many unanswered questions surrounding COVID-19 vaccines, many of which most of the public has never heard of, such as imprinting and Th2 immunopathology. If you choose to get a COVID-19 vaccine, you’re participating in a giant experiment, acting as a guinea pig to see what will ultimately bear out.

That being said, if you or someone you love have received a COVID-19 vaccine and are experiencing side effects, be sure to report it. Children’s Health Defense (CHD) is calling on all who have suffered a side effect from a COVID-19 vaccine to do three things:34

  1. If you live in the U.S., file a report on VAERS
  2. Report the injury on VaxxTracker.com, which is a nongovernmental adverse event tracker (you can file anonymously if you like)
  3. Report the injury on the CHD website

________________________

For more:

“You see it in each country, it’s the same: the curve of vaccination is followed by the curve of deaths.  I’m following this closely and I a doing experiments at the Institute with patients who became sick with Corona after being vaccinated. Luc Montagnier, French virologist

  • The group Doctors For COVID Ethics also recently wrote a paper where they state COVID injections are “needless, ineffective and dangerous.” They delivered notices of liability for COVID-19 “vaccine” harms and deaths to every member of the European parliament.
Please educate yourself on the backstory of COVID.

UPDATE: OSHA Recants

E2EDEvDVkAM9vzE

In an about-face, OSHA succumbs to pressure and recants enforcing 29 CFR 1904’s requiring employers to record worker side effects from COVID-19 injections through May, 2022. (Click on “vaccine related” section)

This is quite amazing in light of the following put out by the CDC:

  • nearly 40% of the population is “fully vaccinated”
  • nearly 50% have had at least one dose
  • 74% of the most vulnerable – over age 65 are “fully vaccinated”
  • nearly 86% having one dose.  Death rates are low across the country.
The only recourse for those damaged by the injections at present is class action lawsuits.